ArticleInternational journal of women's health2025
Oncoplastic or Conventional Breast-Conserving Surgery? Outcomes from a West Java Retrospective Cohort Study.
Article in International journal of women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Breast-conserving surgery (BCS) followed by adjuvant radiotherapy is the standard treatment for early breast cancer in Indonesia. Our aim was to compare the outcomes of BCS with oncoplastic surgery (OPS), a less common method of breast cancer treatment in the country. Patients and Methods: This retrospective cohort study was conducted at Hasan Sadikin General Hospital, Bandung, West Java, Indonesia. Patients with biopsy-proven Stage I to II breast cancer who underwent either OPS or BCS between 1 July 2020 to 30 June 2023, were identified. Data were collected by reviewing patient files and electronic records. Results: A total of 82 patients were included in the study, with 43 (52.4%) undergoing BCS and 39 (47.6%) undergoing OPS. Age in OPS group 39.25 ± 4.9 was not significant difference compare with BCS group 39.86 ± 5.11. The mean tumor volume was higher in the OPS group (34.72 cm Conclusion: OPS is a valid alternative approach to breast cancer treatment that can be offered to women with early stage breast cancer at complex locations owing to the reduced occurrence of positive margins and thus lowered re-excision rates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.